BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26060748)

  • 1. Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.
    Sheikholeslami S; Zarif Yeganeh M; Hoghooghi Rad L; Golab Ghadaksaz H; Hedayati M
    Iran J Public Health; 2014 Feb; 43(2):235-40. PubMed ID: 26060748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.
    Machens A; Frank-Raue K; Lorenz K; Rondot S; Raue F; Dralle H
    Clin Endocrinol (Oxf); 2012 May; 76(5):691-7. PubMed ID: 22111543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [G691S, L769L and S836S ret proto-oncogene polymorphisms are not associated with higher risk to sporadic medullary thyroid carcinoma in Chilean patients].
    Wohllk G N; Soto C E; Bravo A M; Becker C P
    Rev Med Chil; 2005 Apr; 133(4):397-402. PubMed ID: 15953945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
    Elisei R; Cosci B; Romei C; Bottici V; Sculli M; Lari R; Barale R; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3579-84. PubMed ID: 15240649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.
    Neocleous V; Skordis N; Portides G; Efstathiou E; Costi C; Ioannou N; Pantzaris M; Anastasiadou V; Deltas C; Phylactou LA
    J Endocrinol Invest; 2011 Nov; 34(10):764-9. PubMed ID: 21422799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.
    Khan MS; Pandith AA; Iqbal M; Naykoo NA; Khan SH; Rather TA; Mudassar S
    J Cell Biochem; 2015 Aug; 116(8):1712-8. PubMed ID: 25736215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma.
    Fernández RM; Peciña A; Antiñolo G; Navarro E; Borrego S
    Thyroid; 2006 Apr; 16(4):411-7. PubMed ID: 16646689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation.
    Shifrin AL; Ogilvie JB; Stang MT; Fay AM; Kuo YH; Matulewicz T; Xenachis CZ; Vernick JJ
    Surgery; 2010 Dec; 148(6):1274-80; discussion 1280-1. PubMed ID: 21134561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of medullary sponge kidney and hyperparathyroidism with RET G691S/S904S polymorphism: a case report.
    Janjua MU; Long XD; Mo ZH; Dong CS; Jin P
    J Med Case Rep; 2018 Jul; 12(1):197. PubMed ID: 29983117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?
    Baumgartner-Parzer SM; Lang R; Wagner L; Heinze G; Niederle B; Kaserer K; Waldhäusl W; Vierhapper H
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6232-6. PubMed ID: 16118333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.
    Borrello MG; Aiello A; Peissel B; Rizzetti MG; Mondellini P; Degl'Innocenti D; Catalano V; Gobbo M; Collini P; Bongarzone I; Pierotti MA; Greco A; Seregni E
    Endocr Relat Cancer; 2011 Aug; 18(4):519-27. PubMed ID: 21690267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
    Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancies of RET gene and risk of differentiated thyroid carcinoma.
    Rashid FA; Khan MS; Tabassum S; Aiman A; Jadoon MH
    Cancer Biomark; 2022; 33(1):111-121. PubMed ID: 34366324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of RET genetic polymorphisms and haplotypes with papillary thyroid carcinoma in the Portuguese population: a case-control study.
    Santos M; Azevedo T; Martins T; Rodrigues FJ; Lemos MC
    PLoS One; 2014; 9(10):e109822. PubMed ID: 25330015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.
    Gursoy A; Erdogan MF; Erdogan G
    J Endocrinol Invest; 2006 Nov; 29(10):858-62. PubMed ID: 17185892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.
    Colombo C; Minna E; Rizzetti MG; Romeo P; Lecis D; Persani L; Mondellini P; Pierotti MA; Greco A; Fugazzola L; Borrello MG
    Orphanet J Rare Dis; 2015 Mar; 10():25. PubMed ID: 25887804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness.
    Ceolin L; Siqueira DR; Ferreira CV; Romitti M; Maia SC; Leiria L; Crispim D; Ashton-Prolla P; Maia AL
    Eur J Endocrinol; 2012 May; 166(5):847-54. PubMed ID: 22345297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].
    Severskaia NV; Saenko VA; Il'in AA; Chebotareva IV; Rumiantsev PO; Isaev PA; Medvedev VS; Iasmita S
    Mol Biol (Mosk); 2006; 40(3):425-35. PubMed ID: 16813162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma.
    Magalhães PK; de Castro M; Elias LL; Soares EG; Maciel LM
    Thyroid; 2004 Oct; 14(10):848-52. PubMed ID: 15588382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-modifying polymorphisms and C609Y mutation of
    Speak R; Cook J; Harrison B; Newell-Price J
    Endocrinol Diabetes Metab Case Rep; 2016; 2016():. PubMed ID: 27994876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.